The PennZone

  • Home
  • Non-profit
  • Books
  • Health
  • Business
  • Marketing
  • Entertainment
  • Legal
  • Sports

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Dr. Latorial Faison Appointed Poet Laureate of Virginia
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • A New Era Of Social Networking Is Here !
  • Poetry Quarterly Returns in Print With Its Fall 2026 Issue, Featuring 42 Poets
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Pittsburgh Family Law Firm Pollock Begg Celebrates 16th Consecutive Best Law Firms Ranking
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • A Powerful Encounter Awaits Philadelphia: Dr. Mattie Nottage Joins Brother Marcus on Air
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • Beyond Spots & Dots Spreads Holiday Cheer at Old Economy Village's Festival of Trees
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • AI Trading Agents Analyze Pharmaceutical Stocks as Biotech Innovation Draws Attention (LLY, GILD, BSX, AZN, ABBV, MRNA)
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Hope Survives Announces Hidden Impact, Its Second Brain Injury Podcast
  • Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids

Popular on PennZone

  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection - 133
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of - 116
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta - 116
  • What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type - 107
  • Pittsburgh Digital Marketing Agency Moves to Babcock Boulevard in the North Hills - 102
  • LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
  • Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement
  • Sycamore Dove Releases "Loving Every Moment"

Similar on PennZone

  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us